Is targeting of CD47-SIRPα enough for treating hematopoietic malignancy?

Blood. 2012 May 3;119(18):4333-4; author reply 4334-5. doi: 10.1182/blood-2011-11-391367.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Antibodies / therapeutic use*
  • CD47 Antigen / immunology*
  • CD47 Antigen / physiology*
  • Humans
  • Lymphoma, Non-Hodgkin / pathology*
  • Lymphoma, Non-Hodgkin / therapy*

Substances

  • Antibodies
  • CD47 Antigen